←Back to structures
putative_GM-CSF
Euk-VirParapoxvirus_red_deer_HL953
putative_GM-CSF__YP_009112858__Parapoxvirus_red_deer_HL953__1579460
Identity
- Accession:
- YP_009112858 ↗
- Protein ID:
- putative_GM-CSF
- Kingdom:
- euk
Quality
65.8
mean pLDDT
Taxonomy
Bamfordvirae›
Nucleocytoviricota›
Pokkesviricetes›
Chitovirales›
Poxviridae›
Parapoxvirus›
Parapoxvirus_red_deer/HL953
TaxID: 1579460
Cluster
View cluster (92 members)3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 40-178_193-228_260-267
Domain cluster:
rep: NFkB_inhibitor__YP_009408124__Eptesipox_virus__1329402__D30-162_189-224
Pfam (1)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF02250.21 best | Orthopox_35kD | 68.1 | 1.20e-18 | 99.5% | 76.1% |
CATH (13)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 1cq3A00 | 2.60.240.10 | Mainly Beta › Sandwich › Viral Chemokine Inhibitor; Chain A › Major secreted virus protein | 0.70 | 67.0 | 6.19e-01 | 100.0% | 95.1% |
| 3kl0D01 | 2.60.40.1180 | Mainly Beta › Sandwich › Immunoglobulin-like › Golgi alpha-mannosidase II | 0.64 | 24.0 | 3.17e-01 | 79.8% | 58.5% |
| 5brqA03 | 2.60.40.1180 | Mainly Beta › Sandwich › Immunoglobulin-like › Golgi alpha-mannosidase II | 0.59 | 21.0 | 3.08e-01 | 78.1% | 67.9% |
| 4hkjD00 | 2.60.240.30 | Mainly Beta › Sandwich › Viral Chemokine Inhibitor; Chain A › | 0.59 | 54.0 | 5.42e-01 | 100.0% | 95.2% |
| 3f62A00 | 2.60.40.10 | Mainly Beta › Sandwich › Immunoglobulin-like › Immunoglobulins | 0.58 | 31.0 | 3.90e-01 | 90.2% | 85.2% |
| 1pzdA01 | 2.60.40.1480 | Mainly Beta › Sandwich › Immunoglobulin-like › Coatomer, gamma subunit, appendage domain | 0.58 | 34.0 | 3.68e-01 | 91.8% | 66.7% |
| 2qv6B02 | 3.30.70.270 | Alpha Beta › 2-Layer Sandwich › Alpha-Beta Plaits › Reverse transcriptase/Diguanylate cyclase domain | 0.57 | 31.0 | 3.75e-01 | 95.6% | 79.5% |
| 3uebF00 | 3.30.300.100 | Alpha Beta › 2-Layer Sandwich › GMP Synthetase; Chain A, domain 3 › MTH677-like | 0.56 | 31.0 | 4.11e-01 | 84.2% | 99.0% |
| 3a21A02 | 2.60.40.1180 | Mainly Beta › Sandwich › Immunoglobulin-like › Golgi alpha-mannosidase II | 0.54 | 21.0 | 2.89e-01 | 79.2% | 65.9% |
| 2wcoA03 | 2.60.220.10 | Mainly Beta › Sandwich › Chondroitinase Ac; Chain A, domain 3 › Polysaccharide lyase family 8-like, C-terminal | 0.52 | 28.0 | 3.33e-01 | 82.5% | 76.5% |
| 2bkkA01 | 3.30.200.20 | Alpha Beta › 2-Layer Sandwich › Phosphorylase Kinase; domain 1 › Phosphorylase Kinase; domain 1 | 0.52 | 25.0 | 3.45e-01 | 90.2% | 91.1% |
| 6f90A01 | 2.70.98.10 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.51 | 36.0 | 3.18e-01 | 82.0% | 48.3% |
| 7uwjC01 | 2.60.40.2160 | Mainly Beta › Sandwich › Immunoglobulin-like › Interleukin-17 receptor A/B, fibronectin-III-like domain 1 | 0.50 | 26.0 | 3.08e-01 | 90.2% | 70.2% |
ECOD (17)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 2073369 | 527.1.1.1 ↗ | beta sandwiches › Soluble secreted chemokine inhibitor, VCCI › Soluble secreted chemokine inhibitor, VCCI › Soluble secreted chemokine inhibitor, VCCI › Orthopox_35kD | 0.89 | 83.0 | 7.85e-01 | 95.6% | 89.6% |
| 3547494 | 319.1.1.0 ↗ | beta sandwiches › HSP20-like › HSP20-like chaperones › HSP20-like chaperones | 0.66 | 38.0 | 4.56e-01 | 78.1% | 84.2% |
| 3252383 | 12.3.1.46 ↗ | beta sandwiches › Glycosyl hydrolase domain-like › supersandwich › supersandwich › ComC_SSD | 0.61 | 39.0 | 3.59e-01 | 98.4% | 48.9% |
| 3468140 | 304.8.1.45 ↗ | a+b two layers › Alpha-beta plaits › ACT-like › ACT-like › bHLH-TF_ACT-like_plant | 0.61 | 26.0 | 3.58e-01 | 82.5% | 77.8% |
| 3921201 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.61 | 29.0 | 3.84e-01 | 90.7% | 84.2% |
| 221111 | 527.1.1.2 ↗ | beta sandwiches › Soluble secreted chemokine inhibitor, VCCI › Soluble secreted chemokine inhibitor, VCCI › Soluble secreted chemokine inhibitor, VCCI | 0.59 | 54.0 | 5.42e-01 | 100.0% | 95.2% |
| 3367441 | 304.8.1.0 ↗ | a+b two layers › Alpha-beta plaits › ACT-like › ACT-like | 0.59 | 28.0 | 3.67e-01 | 84.7% | 79.8% |
| 3219781 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.59 | 27.0 | 3.47e-01 | 83.6% | 72.4% |
| 1870637 | 12.1.1.0 ↗ | beta sandwiches › Glycosyl hydrolase domain-like › Glycosyl hydrolase domain › Glycosyl hydrolase domain | 0.56 | 23.0 | 3.05e-01 | 80.3% | 66.3% |
| 3265841 | 216.1.1.20 ↗ | a+b two layers › UBC-like › UBC-like › UBC-like › UBC_like | 0.56 | 28.0 | 3.73e-01 | 84.7% | 87.0% |
| 5055194 | 327.18.1.0 ↗ | a+b two layers › Alpha-lytic protease prodomain-like › 40S ribosomal protein S7-A › 40S ribosomal protein S7-A | 0.55 | 22.0 | 3.46e-01 | 73.2% | 100.0% |
| 3328663 | 327.7.1.0 ↗ | a+b two layers › Alpha-lytic protease prodomain-like › Cation efflux protein cytoplasmic domain-like › Cation efflux protein cytoplasmic domain-like | 0.53 | 25.0 | 3.52e-01 | 80.3% | 98.8% |
| 3348189 | 327.7.1.0 ↗ | a+b two layers › Alpha-lytic protease prodomain-like › Cation efflux protein cytoplasmic domain-like › Cation efflux protein cytoplasmic domain-like | 0.52 | 25.0 | 3.44e-01 | 79.2% | 92.9% |
| 3992567 | 220.1.1.0 ↗ | beta barrels › PH domain-like › PH domain-like › PH domain-like | 0.51 | 29.0 | 3.41e-01 | 86.3% | 78.4% |
| 3679255 | 304.55.1.15 ↗ | a+b two layers › Alpha-beta plaits › Origin of replication-binding domains › Origin of replication-binding domains › Helitron_like_N | 0.51 | 32.0 | 3.75e-01 | 98.4% | 88.5% |
| 5043584 | 12.3.1.18 ↗ | beta sandwiches › Glycosyl hydrolase domain-like › supersandwich › supersandwich › Glyco_hydr_116N | 0.50 | 39.0 | 3.22e-01 | 81.4% | 74.8% |
| 3367922 | 304.8.1.45 ↗ | a+b two layers › Alpha-beta plaits › ACT-like › ACT-like › bHLH-TF_ACT-like_plant | 0.50 | 27.0 | 3.65e-01 | 85.2% | 100.0% |